Keros Therapeutics Reports Third Quarter 2025 Financial Results

Go back to Keros Therapeutics Reports Third Quarter 2025 Financial Results
(NASDAQ: KROS) Delayed: 11.03 --0 (-0%)
Previous Close $11.03    52 Week High
Open $11.03    52 Week Low
Day High $11.03    P/E N/A 
Day Low $11.03    EPS
Volume 11